Podcast
Pharmacy Focus: Public Health Matters- Using VaxiTaxi to Promote Better Public Health
VaxiTaxi is aimed to deliver immunity to the community, whether it is a high risk patient, busy family, or a needle shy/needlephobic.
This week's episode features Casey Villhauer, PharmD, Chief Executive Officer of VaxiTaxi, about this business venture and how the emergence of the COVID-19 pandemic influenced this idea to help eliminate barriers to patient care.
Casey Villhauer is a pharmacist whose work focuses on developing sustainable healthcare practices, eliminating barriers to patient care, and promoting public-private partnerships. Dr. Villhauer has been recognized for her leadership and disruptive thinking by the National Alliance of State Pharmacy Associations, Pharmacy Times, Iowa Pharmacy Association, Upsher-Smith Laboratories, and GoodRx. Her vaccine distribution startup, Vaxi Taxi, has been highlighted by Fortune, USA Today, and the American Pharmacist Association. Dr. Villhauer is a member of various state and national organizations, including the Iowa Public Health Association, Pharmacy Association, Cancer Consortium, Immunization Coalition, and the American Pharmacist Association.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children at Increased Risk
